Viewing Study NCT00000802


Ignite Creation Date: 2025-12-25 @ 3:55 AM
Ignite Modification Date: 2025-12-26 @ 2:46 AM
Study NCT ID: NCT00000802
Status: COMPLETED
Last Update Posted: 2021-11-04
First Post: 1999-11-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pneumonia, Pneumocystis Carinii View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pneumonia, Pneumocystis carinii View
None Dapsone View
None Antifungal Agents View
None Acquired Immunodeficiency Syndrome View
None atovaquone View